Allogeneic hematopoietic cell transplantation (matched unrelated donor) with reduced-intensity conditioning and mesenchymal stem cell co-transplantation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic hematopoietic cell transplantation (matched unrelated donor) with reduced-intensity conditioning and mesenchymal stem cell co-transplantation, covering 2018-08-06 to 2018-08-06. Get the full timeline:
Most recent: Clinical Trial Update: Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs [Phase 2]